T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26/08/26	₩2,480.00	-1.00%	124,722
25/08/26	₩2,505.00	+3.09%	151,631
24/08/26	₩2,430.00	-0.82%	127,218
21/08/26	₩2,450.00	-2.39%	110,852
20/08/26	₩2,510.00	+4.37%	95,966

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 25/08/2026			5-day change	1st Jan Change
2,505.00 ^KRW	+3.09%		+1.42%	-35.93%

01-21	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
22/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	118B 85.35M 73.29M 68.68M 62.89M 118M 8.14B 119M 814M 316M 4.11B 321M 313M 13.63B	P/E 2024	-12.2x	P/E 2025	-3.58x
Enterprise Value	140B 101M 86.74M 81.29M 74.43M 140M 9.64B 141M 963M 374M 4.86B 379M 371M 16.13B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	78.94%	Yield 2024 *	-	Yield 2025	-

01-21	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
22/09/24	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
04/08/24	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
22/07/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
03/07/24	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
24/06/24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
21/12/23	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
13/12/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
18/10/23	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
03/08/23	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
25/07/23	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
15/05/23	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
20/09/21	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	+3.09%
1 week	+1.42%
Current month	-16.50%
1 month	+7.05%
3 months	+8.91%
6 months	-26.65%
Current year	-35.93%

T&R Biofab Co., Ltd. Share Price

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news : T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	2,365	2,550
1 month	2,265	3,265
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	11,575
5 years	1,127	36,333.33
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
06/03/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
06/03/25	Eun-kyung Cho	Others		15,492	0.0719%
26/02/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	+3.09%	+1.42%	+11.54%	-75.44%	86.24M
STRYKER CORPORATION	-0.28%	-3.03%	-16.40%	+18.54%	127B
SMITH & NEPHEW PLC	+0.28%	+0.23%	-22.39%	-0.19%	12.25B
GLAUKOS CORPORATION	-0.45%	-4.74%	+92.53%	+144.41%	10.69B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+2.13%	-4.21%	-51.63%	-68.92%	4.19B
DOUBLE MEDICAL TECHNOLOGY INC.	+0.57%	+4.02%	-22.01%	+58.76%	2.78B
INSPIRE MEDICAL SYSTEMS, INC.	+1.20%	+0.18%	-32.64%	-71.33%	1.77B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.12%	-0.84%	-23.32%	-12.99%	1.64B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.47%	-3.59%	-36.96%	-38.68%	1.57B
Average	+0.90%	+0.86%	-11.26%	-5.09%	17.98B
Weighted average by Cap.	-0.13%	-0.46%	-11.09%	+21.96%

	2024	2025
Net sales	4.87B 3.52M 3.02M 2.83M 2.59M 4.88M 336M 4.9M 33.55M 13.02M 169M 13.22M 12.93M 562M	26.97B 19.47M 16.72M 15.67M 14.35M 27.02M 1.86B 27.13M 186M 72.03M 937M 73.14M 71.52M 3.11B
Net income	-7.68B -5.54M -4.76M -4.46M -4.09M -7.69M -529M -7.72M -52.85M -20.51M -267M -20.82M -20.36M -885M	-34.94B -25.23M -21.67M -20.3M -18.59M -35.01M -2.41B -35.15M -241M -93.34M -1.21B -94.77M -92.67M -4.03B
Net Debt	28.78B 20.78M 17.84M 16.72M 15.31M 28.84M 1.98B 28.95M 198M 76.87M 1B 78.05M 76.33M 3.32B	21.7B 15.67M 13.46M 12.61M 11.55M 21.75M 1.5B 21.83M 149M 57.97M 754M 58.86M 57.55M 2.5B